Upstream Bio, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue 2.38M2.37M
Gross Profit -0.99M-4.21M
Operating items
Research & Development 31.80M62.97M
Selling, General & Administrative 10.70M17.17M
Restructuring Costs 1.00M1.98M
Other Operating Expenses -1.00M-1.98M
Operating Expenses 42.49M80.13M
Operating Income -40.11M-77.76M
EBIT -40.11M-77.76M
Non-operating items
Interest & Investment Income 4.17M12.12M
Non Operating Income 19.58M14.96M
Net income details
EBT -35.95M-65.64M
Profit After Tax -20.54M-62.81M
Income from Continuing Operations -35.95M-65.64M
Consolidated Net Income -35.95M-65.64M
Income towards Parent Company -35.95M-65.64M
Preferred Dividend Payments 17.72M13.59M
Net Income towards Common Stockholders -38.26M-76.39M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 36.34M53.60M
Shares Outstanding (Diluted Average) 2.95M13.68M
EBITDA -40.11M-77.76M
Shares Outstanding 2.99M53.60M